These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 14967798
1. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Moore MM, Elpern DJ, Carter DJ. Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798 [Abstract] [Full Text] [Related]
5. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. Hashimoto Y, Kanto H, Itoh M. J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392 [Abstract] [Full Text] [Related]
9. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E. Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365 [No Abstract] [Full Text] [Related]
10. Cutaneous reactions to interferon and ribavirin. Chamberlain AJ, Poon E. Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557 [No Abstract] [Full Text] [Related]
11. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment. Vázquez-López F, Manjón-Haces JA, Pérez-Alvarez R, Pérez-Oliva N. Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535 [No Abstract] [Full Text] [Related]
12. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. González-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, Mieli-Vergani G, Lurie Y, Martin S, Lang T, Baczkowski A, Geffner M, Gupta S, Laughlin M, International Pediatric Hepatitis C Therapy Group. Hepatology; 2005 Nov; 42(5):1010-8. PubMed ID: 16250032 [Abstract] [Full Text] [Related]
13. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Cogrel O, Doutre MS, Marlière V, Beylot-Barry M, Couzigou P, Beylot C. Br J Dermatol; 2002 Feb; 146(2):320-4. PubMed ID: 11903249 [Abstract] [Full Text] [Related]
14. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. N Engl J Med; 2002 Sep 26; 347(13):975-82. PubMed ID: 12324553 [Abstract] [Full Text] [Related]
15. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C. Tavakoli-Tabasi S, Bagree A. J Clin Gastroenterol; 2012 Feb 26; 46(2):162-7. PubMed ID: 21814144 [Abstract] [Full Text] [Related]
16. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection. Conde-Taboada A, de la Torre C, Feal C, Mayo E, Gonzalez-Sixto B, Cruces MJ. Br J Dermatol; 2005 Nov 26; 153(5):1070-2. PubMed ID: 16225630 [No Abstract] [Full Text] [Related]
17. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Kartal ED, Alpat SN, Ozgunes I, Usluer G. Eur J Gastroenterol Hepatol; 2007 Sep 26; 19(9):817-20. PubMed ID: 17700271 [Abstract] [Full Text] [Related]
19. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Wirth S, Pieper-Boustani H, Lang T, Ballauff A, Kullmer U, Gerner P, Wintermeyer P, Jenke A. Hepatology; 2005 May 26; 41(5):1013-8. PubMed ID: 15793840 [Abstract] [Full Text] [Related]